$275 M

CRVS Mkt cap, 20-Sep-2018
Corvus Pharmaceuticals Net income (Q2, 2018)-25.9 M
Corvus Pharmaceuticals EBIT (Q2, 2018)-26.9 M
Corvus Pharmaceuticals Cash, 30-Jun-201828.1 M

Corvus Pharmaceuticals Income Statement

Annual

USDFY, 2016

R&D expense

38 k

General and administrative expense

123 k

Operating expense total

161 k

EBIT

(161 k)

Net Income

(161 k)

Quarterly

USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

R&D expense

7.7 m13.5 m12.4 m12.1 m21.8 m

General and administrative expense

2.8 m2.7 m2.8 m2.5 m5.1 m

Operating expense total

10.5 m16.2 m15.2 m14.6 m26.9 m

EBIT

(10.5 m)(16.2 m)(15.2 m)(14.6 m)(26.9 m)

Interest income

181 k193 k343 k

Net Income

(6.3 m)(15 m)(10.3 m)(16 m)(15 m)(14.3 m)(25.9 m)

Corvus Pharmaceuticals Balance Sheet

Quarterly

USDQ1, 2016Q2, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Cash

4.1 m4.3 m10.5 m34.1 m102.6 m28.1 m

Current Assets

154.1 m153.5 m123.1 m111.6 m145.2 m134.4 m

PP&E

2.6 m2.8 m3.1 m3 m2.5 m2.3 m

Total Assets

157.2 m156.9 m127.1 m115.5 m148.7 m137.9 m

Accounts Payable

1.6 m1.3 m2.4 m4.1 m3.5 m2.3 m

Current Liabilities

3.4 m3.6 m7.6 m9.5 m10.6 m9.8 m

Total Liabilities

4.7 m5 m8.9 m10.7 m11.5 m10.5 m

Additional Paid-in Capital

190.4 m198.4 m202.2 m203.7 m275.1 m276.9 m

Retained Earnings

(37.8 m)(46.5 m)(83.9 m)(98.9 m)(137.8 m)(149.5 m)

Total Equity

152.6 m152 m118.2 m104.8 m137.2 m127.4 m

Financial Leverage

1 x1 x1.1 x1.1 x1.1 x1.1 x

Corvus Pharmaceuticals Cash Flow

Annual

USDFY, 2016

Net Income

(161 k)

Accounts Payable

1.9 m

Quarterly

USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Net Income

(6.3 m)(15 m)(10.3 m)(16 m)(14.3 m)(25.9 m)

Depreciation and Amortization

106 k250 k219 k439 k

Accounts Payable

(193 k)129 k2.4 m2.4 m45 k(1.2 m)

Cash From Operating Activities

(5.6 m)(11.8 m)(11 m)(21.9 m)

Purchases of PP&E

(614 k)(1.5 m)(6 k)(60 k)

Cash From Investing Activities

(58.7 m)(59.4 m)3.6 m(60 m)

Cash From Financing Activities

64.3 m71.4 m64.9 m64.9 m

Corvus Pharmaceuticals Ratios

USDY, 2018

Financial Leverage

1.1 x
Report incorrect company information

Corvus Pharmaceuticals Operating Metrics

FY, 2016

Patent Applications

11

Patents Licensed

18
Report incorrect company information